Seeking Alpha

Bank of America Merrill Lynch makes a couple valuation calls in healthcare this morning, upping...

Bank of America Merrill Lynch makes a couple valuation calls in healthcare this morning, upping Merck (MRK +1.2%) to Buy on optimism over its osteoporosis drug, and moving to Neutral on Bristol-Myers (BMY -0.9%) due to its limited total-return potential.
Comments (1)
  • gdavidson99
    , contributor
    Comments (37) | Send Message
     
    That is good news...now if we can just get Merck to upgrade its rating of Bank of America to "Buy" everything would be peachy with me.
    4 Mar 2013, 10:46 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|